Your browser doesn't support javascript.
loading
Factors associated with COVID-19 booster vaccine hesitancy: a nationwide, cross-sectional survey in Japan.
Takamatsu, A; Honda, H; Miwa, T; Tabuchi, T; Taniguchi, K; Shibuya, K; Tokuda, Y.
Afiliação
  • Takamatsu A; Department of Microbiology, Juntendo University Graduate School of Medicine, Tokyo, Japan. Electronic address: chrise.type@gmail.com.
  • Honda H; Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan. Electronic address: hhhhonda@gmail.com.
  • Miwa T; Department of Infectious Diseases, University of Tokyo Hospital, Tokyo, Japan. Electronic address: toshiki.miwa1993@gmail.com.
  • Tabuchi T; Tokyo Foundation for Policy Research, Tokyo, Japan; Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan. Electronic address: tabuchitak@gmail.com.
  • Taniguchi K; Tokyo Foundation for Policy Research, Tokyo, Japan; National Hospital Organization, Mie Medical Center, Mie, Japan. Electronic address: tngk7g04@gmail.com.
  • Shibuya K; Tokyo Foundation for Policy Research, Tokyo, Japan. Electronic address: kenjishibuya1@gmail.com.
  • Tokuda Y; Tokyo Foundation for Policy Research, Tokyo, Japan; Muribushi Okinawa Center for Teaching Hospitals, Okinawa, Japan. Electronic address: yasuharu.tokuda@gmail.com.
Public Health ; 223: 72-79, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37619504
OBJECTIVES: COVID-19 vaccine hesitancy/fatigue is increasing as the pandemic enters the endemic phase. The present study aimed to explore current perceptions about COVID-19 booster vaccination among the Japanese public. STUDY DESIGN: This was a cross-sectional study. METHODS: This cross-sectional study used data from the Japan COVID-19 and Society Internet Survey conducted in September 2021 and September 2022. The public's perceptions of COVID-19 vaccination and factors associated with COVID-19 booster vaccine hesitancy were analyzed. RESULTS: In total, 56,735 respondents were included. In the Japan COVID-19 and Society Internet Survey 2021, 75.1% of the participants (21,126/28,118) had completed the primary vaccination series. In the 2022 survey, 74.1% of the respondents (21,216/28,617) completed the primary series of vaccination with booster doses. The proportion of fear toward COVID-19 and obtaining information about COVID-19 has decreased from 2021 to 2022. Factors independently associated with booster vaccine hesitancy were young age (range: 18-29 years; adjusted odds ratio [aOR]: 6.56), history of COVID-19 (aOR: 1.82), distrust of the Japanese government's COVID-19 prevention measures (aOR: 1.55), lack of confidence in COVID-19 vaccine efficacy (aOR: 1.30), lack of confidence in COVID-19 vaccine safety (aOR: 1.62), low reliance on the COVID-19 vaccine (aOR: 1.92), and belief in COVID-19 conspiracy theories (aOR: 1.77). CONCLUSIONS: Providing clear and trustworthy information is critically important, especially targeted and tailored messages for the young generation, to promoting COVID-19 booster vaccination. Policymakers should therefore develop consistent and transparent communication strategies and the ability to respond promptly and flexibly to mitigate the negative impact of COVID-19 on the public while preparing for the next pandemic.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Public Health Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Public Health Ano de publicação: 2023 Tipo de documento: Article